Metformin and ursodeoxycholic acid do not improve long COVID recovery
1. In this randomized controlled trial, neither metformin nor ursodeoxycholic acid improved recovery from long COVID compared with placebo in ...
Tag: metformin
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia
1. Glucagon-like peptide-1 receptor agonists (GLP-1RA) in combination with progestins are significantly more effective at reducing endometrial cancer (EC) risk ...
Metformin is associated with lowering maternal hyperglycemia and reducing the risk of neonatal hypoglycemia among pregnant patients at risk of preterm delivery
1. Among pregnant patients at risk of preterm delivery, metformin was associated with lower mean maternal glucose values and a ...
Low-dose combined hormonal contraceptives may be effective in managing symptoms of polycystic ovarian syndrome without increasing the prevalence of metabolic syndrome
1. Low-dose combined hormonal contraceptives managed symptoms of polycystic ovarian syndrome (PCOS) without increasing the prevalence of metabolic syndrome among ...
Canagliflozin may significantly improve glycemic control in children and adolescents with type 2 diabetes
1. In this randomized controlled trial involving children and adolescents with type 2 diabetes mellitus, canagliflozin was associated with significantly ...
#VisualAbstract: Oral Glucose-Lowering Agents are Not Noninferior to Insulin for Gestational Diabetes
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Early intensive glycemic control reduces long-term risk of death and myocardial infarction in patients with type 2 diabetes
1. Sulfonylurea, insulin therapy, and metformin resulted in a significant relative risk reduction for all-cause mortality and myocardial infarction. 2. ...
Metformin may reduce all-cause mortality in cancer survivors
1. Among US cancer survivors, metformin was associated with a lower risk of cardiometabolic diseases, all-cause mortality, and cardiometabolic mortality. ...
Metformin use may decrease risk of osteoarthritis development
1. In this retrospective cohort study, individuals with diabetes treated with metformin had a significantly lower risk of developing osteoarthritis ...
Meta-analysis shows significant decrease in age-related macular degeneration risk with metformin use
1. In a systematic review and meta-analysis of observational studies on patients with diabetes, metformin use was associated with a ...
